AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 130 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 3.37 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,192,000 | +11.4% | 34,600 | -46.0% | 0.02% | -5.9% |
| Q2 2020 | $1,070,000 | -7.6% | 64,060 | +15.9% | 0.02% | +70.0% |
| Q3 2019 | $1,158,000 | +276.0% | 55,278 | +300.6% | 0.01% | +233.3% |
| Q1 2019 | $308,000 | -54.2% | 13,800 | -50.9% | 0.00% | -62.5% |
| Q4 2018 | $672,000 | -33.3% | 28,088 | -23.9% | 0.01% | -33.3% |
| Q3 2018 | $1,007,000 | +24.8% | 36,916 | +23.1% | 0.01% | +9.1% |
| Q2 2018 | $807,000 | +7.3% | 30,000 | +50.8% | 0.01% | -15.4% |
| Q4 2017 | $752,000 | – | 19,891 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
| Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
| Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
| AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
| Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
| Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
| Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
| EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |